Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel

There are few data regarding disparities in overall survival (OS) between Asian and white men with metastatic castration-resistant prostate cancer (mCRPC). We compared OS of Asian and white mCRPC men treated in phase III clinical trials with docetaxel and prednisone (DP) or a DP-containing regimen....

Descripción completa

Detalles Bibliográficos
Autores principales: Halabi, Susan, Dutta, Sandipan, Tangen, Catherine M, Rosenthal, Mark, Petrylak, Daniel P, Thompson, Ian M, Chi, Kim N, De Bono, Johann S, Araujo, John C, Logothetis, Christopher, Eisenberger, Mario A, Quinn, David I, Fizazi, Karim, Morris, Michael J, Higano, Celestia S, Tannock, Ian F, Small, Eric J, Kelly, William Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190204/
https://www.ncbi.nlm.nih.gov/pubmed/32368717
http://dx.doi.org/10.1093/jncics/pkaa003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190204/
https://www.ncbi.nlm.nih.gov/pubmed/32368717
http://dx.doi.org/10.1093/jncics/pkaa003

Ejemplares similares